The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that Arixtra patients will be less likely to experience wound infection than patients who have received low-molecular weight heparin, coumadin or aspirin with mechanical compression.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Paul Di Cesare,MD; University of California, Davis
• Treatments: Fondaparinux; PENTA

Criteria

Inclusion Criteria:

• All primary unilateral TKA and THA cases will be included.

Exclusion Criteria:

• Patients less than 50 kg, Patients with CrCl<30ml/min. Revision and bilateral procedures will be excluded.